What is the most recent earnings date for DRIO stock?
DARIOHEALTH CORP (DRIO) last reported earnings on 3/9/2026.
NASDAQ:DRIO • US23725P3082
Past quarterly earnings results for DARIOHEALTH CORP (DRIO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 2.96 | -5.00 | 159.22% | 159.20% | 5.007M | 5.778M | -13.34% | -32.55% |
| Q2 2025 | -3.60 | -4.76 | 24.37% | -125.00% | 5.369M | 7.044M | -23.78% | -14.16% |
| Q1 2025 | -2.80 | -2.38 | -17.64% | 30.00% | 6.752M | 7.625M | -11.45% | 17.26% |
| Q4 2024 | -1.80 | -6.80 | 73.53% | 82.00% | 7.604M | 7.535M | 0.92% | 110.29% |
| Q3 2024 | -5.00 | -5.58 | 10.33% | 48.98% | 7.423M | 7.545M | -1.62% | 111.00% |
| Q2 2024 | -1.60 | -11.32 | 85.87% | 86.21% | 6.255M | 8.072M | -22.51% | 1.67% |
| Q1 2024 | -4.00 | -8.26 | 51.59% | 55.56% | 5.758M | 6.893M | -16.47% | -18.51% |
| Q4 2023 | -10.00 | -11.29 | 11.41% | 1.96% | 3.616M | 3.643M | -0.74% | -46.90% |
| Q3 2023 | -9.80 | -9.38 | -4.43% | 23.44% | 3.518M | 5.449M | -35.44% | -46.78% |
| Q2 2023 | -11.60 | -10.65 | -8.93% | 21.62% | 6.152M | 6.588M | -6.62% | -0.45% |
| Q1 2023 | -9.00 | -10.16 | 11.41% | 39.19% | 7.066M | 6.838M | 3.33% | -12.33% |
| Q4 2022 | -10.20 | -13.30 | 23.31% | 53.21% | 6.81M | 6.413M | 6.19% | 12.94% |
| Q3 2022 | -12.80 | -15.56 | 17.75% | 45.76% | 6.61M | 6.357M | 3.98% | 17.41% |
| Q2 2022 | -14.80 | -14.54 | -1.82% | 25.25% | 6.18M | 8.4M | -26.43% | 17.49% |
| Q1 2022 | -14.80 | -19.53 | 24.20% | 19.57% | 8.06M | 7.012M | 14.95% | 123.89% |
| Q4 2021 | -21.80 | -21.54 | -1.22% | -2.83% | 6.03M | 6.17M | -2.27% | 189.90% |
| Q3 2021 | -23.60 | -19.09 | -23.63% | -66.20% | 5.63M | 5.889M | -4.40% | 175.98% |
| Q2 2021 | -19.80 | -17.44 | -13.52% | -45.59% | 5.26M | 5.186M | 1.43% | 193.85% |
| Q1 2021 | -18.40 | -21.25 | 13.41% | 41.40% | 3.6M | 4.044M | -10.98% | 115.57% |
| Q4 2020 | -21.20 | -16.56 | -27.98% | - | 2.08M | 2.126M | -2.16% | - |
| Q3 2020 | -14.20 | -13.94 | -1.87% | - | 2.04M | 1.993M | 2.36% | - |
| Q2 2020 | -13.60 | -28.51 | 52.30% | - | 1.79M | 1.586M | 12.86% | - |
| Q1 2020 | -31.40 | -15.30 | -105.23% | - | 1.67M | 1.785M | -6.44% | - |
Notes
DARIOHEALTH CORP (DRIO) last reported earnings on 3/9/2026.
DARIOHEALTH CORP (DRIO) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, DARIOHEALTH CORP (DRIO) has beaten EPS estimates in 3 out of 4 releases.